Evidence map›Paper›PMID 21576386›Full record

ArticleThe Journal of experimental medicine2011

Lipid phosphate phosphatase 3 enables efficient thymic egress.

Béatrice Bréart, Willy D Ramos-Perez, Alejandra Mendoza, Abdelghaffar K Salous, Michael Gobert, Yong Huang, Ralf H Adams, Juan J Lafaille, Diana Escalante-Alcalde, Andrew J Morris and 1 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed.

  1. Article
  2. Article
  3. Regulation of cellular and systemic sphingolipid homeostasis.Nature reviews. Molecular cell biology · 2024
    Review
  4. Targeting sphingosine kinase 1 in p53KO thymic lymphoma.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Lysolipids in Vascular Development, Biology, and Disease.Arteriosclerosis, thrombosis, and vascular biology · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Béatrice BréartProgram in Molecular Pathogenesis and Department of Pathology, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA.
Willy D Ramos-Perez
Alejandra Mendoza
Abdelghaffar K Salous
Michael Gobert
Yong Huang
Ralf H Adams
Juan J Lafaille
Diana Escalante-Alcalde
Andrew J Morris
Susan R Schwab

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
THROMBOSPONDIN1 MEDIATES MACROPHAGE INFILTRATION INTO ADIPOSE TISSUE AND PROMOTEP20RR021954 · NCRR · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2008 to 2011
$8.3M
The role of SPNS2 in T cell responsesR01AI085166 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Susan Ruth Schwab · 2011 to 2026
$6.5M
TRAINING PROGRAM IN DEVELOPMENTAL GENETICS.T32HD007520 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TREISMAN, JESSICA E · 1999 to 2023
$3.9M
Role of Lipid Phosphatases in Cholesterol and Triglyceride SynthesisR01GM050388 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI MORRIS, ANDREW J · 1994 to 2011
$2.7M
Thermo/Finnigan TSQ AM Triple Stage Quadrupole Mass SpectrometerS10RR024598 · NCRR · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2008 to 2008
$493k
NCI NIH HHS 5 P30CA16087-31NCI NIH HHS P30 CA016087NCRR NIH HHS P20 RR021954NCRR NIH HHS P20RR021954NCRR NIH HHS S10 RR024598NIAID NIH HHS 1R01AI085166-01A1NIAID NIH HHS R01 AI085166NICHD NIH HHS T32 HD007520NICHD NIH HHS T32-HD007520NIGMS NIH HHS R01 GM050388NIGMS NIH HHS R01GM50388
6 · The paper itself

Abstract

The signaling lipid sphingosine-1-phosphate (S1P) stabilizes the vasculature, directs lymphocyte egress from lymphoid organs, and shapes inflammatory responses. However, little is known about how S1P distribution is controlled in vivo, and it is not clear how a ubiquitously made lipid functions as a signal that requires precise spatial and temporal control. We have found that lipid phosphate phosphatase 3 (LPP3) enables efficient export of mature T cells from the thymus into circulation, and several lines of evidence suggest that LPP3 promotes exit by destroying thymic S1P. Although five additional S1P-degrading enzymes are expressed in the thymus, they cannot compensate for the loss of LPP3. Moreover, conditional deletion of LPP3 in either epithelial cells or endothelial cells is sufficient to inhibit egress. These results suggest that S1P generation and destruction are tightly regulated and that LPP3 is essential to establish the balance.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensEndothelial CellsEpithelial CellsGene DeletionGreen Fluorescent ProteinsLectins, C-TypeLysophospholipidsMass SpectrometryMiceMice, TransgenicMicroscopy, ConfocalPhosphatidate PhosphataseReceptors, LysosphingolipidAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensGreen Fluorescent ProteinsLectins, C-TypeLysophospholipidsPhosphatidate PhosphatasePlpp3 protein, mouseReceptors, LysosphingolipidS1pr1 protein, mouseSphingosinesphingosine 1-phosphateSphingosine-1-Phosphate Receptors

Identifiers

PMID21576386
PMCPMC3173249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.